You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KROS Buy Disclosure
Bienaime Jean Jacques · SEC Form 4 · Filed Jun 17, 2026
Buy
Calculated transaction value
$10.19K
Bienaime Jean Jacques Director
KROS
Keros Therapeutics
KROS
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
KROS daily price context
Close on/before transaction
$10.24
Jun 15, 2026
First close after public filing
$10.65
Jun 18, 2026
30-day return after filing
-0.09%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,000 shares @ $10.19
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001221590-26-000021
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$10.19K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Keros Therapeutics, Inc. KROS Current | Buy | Jun 15, 2026 | $10.19K |